(BKMC) BNY Mellon US Mid Cap Core - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US09661T2069 • Mid-Cap Blend
BKMC: Medium-Cap, US, Stocks, Equity, Derivatives, ETFs
BNY Mellon US Mid Cap Core Equity ETF (NYSE ARCA: BKMC) is a mid-cap blend ETF that seeks to provide exposure to medium-capitalization U.S. companies. Under normal market conditions, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of mid-cap U.S. companies, ETFs tracking such securities, and derivatives that replicate the economic characteristics of these securities. The fund is designed to track the performance of the BNY Mellon Mid Cap USD Equity Index, which is a free-float market capitalization-weighted index comprising 400 mid-capitalization U.S. companies. The fund is non-diversified, meaning it may concentrate its investments in a smaller number of securities compared to a diversified fund.
The funds technical indicators suggest mixed short-term momentum. As of the latest data, BKMC is trading at $100.53, below its 20-day and 50-day simple moving averages (SMAs) of $104.45 and $104.09, respectively, but above its 200-day SMA of $99.92. This indicates potential short-term weakness but longer-term bullish momentum. The Average True Range (ATR) of 1.16 reflects moderate volatility, while the average 20-day volume of 10,861 shares suggests limited liquidity compared to larger ETFs. The funds assets under management (AUM) total $548.77 million, indicating a mid-sized ETF with reasonable market presence.
Over the next three months, BKMC is expected to trade in a range influenced by its technical and fundamental factors. Based on the current SMA trends, the fund may face resistance near the $104 level, while support is likely to hold around $99. The ATR of 1.16 suggests that price fluctuations may remain moderate, with potential downside risks tied to broader market conditions. Given its mid-cap focus, BKMC could benefit from a rotating investor preference for smaller-cap stocks if market sentiment shifts toward growth. However, its non-diversified nature may amplify volatility compared to more diversified mid-cap ETFs.
Additional Sources for BKMC ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BKMC ETF Overview
Market Cap in USD | 530m |
Category | Mid-Cap Blend |
TER | 0.04% |
IPO / Inception | 2020-04-07 |
BKMC ETF Ratings
Growth 5y | 73.6% |
Fundamental | - |
Dividend | 63.3% |
Rel. Strength Industry | -9.1 |
Analysts | - |
Fair Price Momentum | 86.69 USD |
Fair Price DCF | - |
BKMC Dividends
Dividend Yield 12m | 1.59% |
Yield on Cost 5y | 3.12% |
Annual Growth 5y | 18.51% |
Payout Consistency | 98.8% |
BKMC Growth Ratios
Growth Correlation 3m | -44.2% |
Growth Correlation 12m | 81.2% |
Growth Correlation 5y | 70.7% |
CAGR 5y | 14.56% |
CAGR/Max DD 5y | 0.58 |
Sharpe Ratio 12m | 1.23 |
Alpha | -10.61 |
Beta | 1.03 |
Volatility | 20.49% |
Current Volume | 10.2k |
Average Volume 20d | 8.5k |
As of March 09, 2025, the stock is trading at USD 97.70 with a total of 10,248 shares traded.
Over the past week, the price has changed by -3.71%, over one month by -7.18%, over three months by -9.54% and over the past year by +3.00%.
Yes. Based on ValueRay Analyses, BNY Mellon US Mid Cap Core (NYSE ARCA:BKMC) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.56 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKMC as of March 2025 is 86.69. This means that BKMC is currently overvalued and has a potential downside of -11.27%.
BNY Mellon US Mid Cap Core has no consensus analysts rating.
According to ValueRays Forecast Model, BKMC BNY Mellon US Mid Cap Core will be worth about 101.3 in March 2026. The stock is currently trading at 97.70. This means that the stock has a potential upside of +3.64%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 101.3 | 3.6% |